Pluri, Inc. (PLUR)
0.9532
-0.05
(-4.68%)
USD |
NASDAQ |
Oct 09, 16:00
1.00
+0.05
(+4.91%)
After-Hours: 20:00
Pluri EPS Diluted (Quarterly) : -0.5432 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5432 |
| March 31, 2026 | -0.5518 |
| December 31, 2025 | -0.7066 |
| September 30, 2025 | -0.6503 |
| June 30, 2025 | -0.9625 |
| March 31, 2025 | -0.9365 |
| December 31, 2024 | -0.5323 |
| September 30, 2024 | -1.077 |
| June 30, 2024 | -1.059 |
| March 31, 2024 | -1.014 |
| December 31, 2023 | -0.945 |
| September 30, 2023 | -0.9602 |
| June 30, 2023 | -1.253 |
| March 31, 2023 | -1.527 |
| December 31, 2022 | -1.956 |
| September 30, 2022 | -1.504 |
| June 30, 2022 | -2.223 |
| March 31, 2022 | -2.446 |
| December 31, 2021 | -2.723 |
| September 30, 2021 | -2.858 |
| June 30, 2021 | -3.647 |
| March 31, 2021 | -3.850 |
| December 31, 2020 | -3.914 |
| September 30, 2020 | -2.660 |
| June 30, 2020 | -2.553 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.370 |
| December 31, 2019 | -3.199 |
| September 30, 2019 | -3.707 |
| June 30, 2019 | -4.116 |
| March 31, 2019 | -6.878 |
| December 31, 2018 | -5.999 |
| September 30, 2018 | -6.184 |
| June 30, 2018 | -6.326 |
| March 31, 2018 | -0.80 |
| December 31, 2017 | -6.40 |
| September 30, 2017 | -6.40 |
| June 30, 2017 | -5.60 |
| March 31, 2017 | -7.20 |
| December 31, 2016 | -6.40 |
| September 30, 2016 | -6.40 |
| June 30, 2016 | -6.40 |
| March 31, 2016 | -7.20 |
| December 31, 2015 | -4.00 |
| September 30, 2015 | -5.60 |
| June 30, 2015 | -5.60 |
| March 31, 2015 | -8.00 |
| December 31, 2014 | -7.20 |
| September 30, 2014 | -7.20 |
| June 30, 2014 | -7.20 |
| March 31, 2014 | -11.20 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.074 |
| Evogene Ltd. | -0.1449 |
| Scinai Immunotherapeutics Ltd. | -3.662 |
| CollPlant Biotechnologies Ltd. | -1.890 |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.193M |
| Revenue (Quarterly) | 0.335M |
| Total Expenses (Quarterly) | 6.215M |
| Enterprise Value | 43.00M |
| Gross Profit Margin (Quarterly) | 21.49% |
| Profit Margin (Quarterly) | -1.85K% |
| Earnings Yield | -257.2% |
| Normalized Earnings Yield | -259.49 |